- Home
- PAGP vs HAE Comparison
PAGP vs HAE Comparison
Compare PAGP & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAGP
- HAE
- Stock Information
- Founded
- PAGP 2013
- HAE 1971
- Country
- PAGP United States
- HAE United States
- Employees
- PAGP N/A
- HAE N/A
- Industry
- PAGP Natural Gas Distribution
- HAE Medical/Dental Instruments
- Sector
- PAGP Energy
- HAE Health Care
- Exchange
- PAGP Nasdaq
- HAE Nasdaq
- Market Cap
- PAGP 3.6B
- HAE 3.3B
- IPO Year
- PAGP 2013
- HAE 1991
- Fundamental
- Price
- PAGP $17.75
- HAE $68.56
- Analyst Decision
- PAGP Buy
- HAE Strong Buy
- Analyst Count
- PAGP 7
- HAE 9
- Target Price
- PAGP $20.50
- HAE $99.78
- AVG Volume (30 Days)
- PAGP 1.7M
- HAE 578.9K
- Earning Date
- PAGP 05-09-2025
- HAE 05-08-2025
- Dividend Yield
- PAGP 8.64%
- HAE N/A
- EPS Growth
- PAGP N/A
- HAE 44.54
- EPS
- PAGP 0.74
- HAE 3.31
- Revenue
- PAGP $50,089,000,000.00
- HAE $1,360,824,000.00
- Revenue This Year
- PAGP N/A
- HAE N/A
- Revenue Next Year
- PAGP $15.57
- HAE $6.76
- P/E Ratio
- PAGP $23.94
- HAE $20.46
- Revenue Growth
- PAGP 3.56
- HAE 3.96
- 52 Week Low
- PAGP $16.61
- HAE $55.30
- 52 Week High
- PAGP $22.31
- HAE $94.99
- Technical
- Relative Strength Index (RSI)
- PAGP 42.00
- HAE 54.87
- Support Level
- PAGP $17.45
- HAE $66.42
- Resistance Level
- PAGP $18.17
- HAE $68.75
- Average True Range (ATR)
- PAGP 0.32
- HAE 1.30
- MACD
- PAGP 0.01
- HAE -0.26
- Stochastic Oscillator
- PAGP 17.57
- HAE 45.00
About PAGP Plains GP Holdings L.P. Units representing Limited Partner Interests
Plains GP Holdings LP provides transportation, storage, processing, fractionation, and marketing services for crude oil, refined products, natural gas liquids, liquefied petroleum gas, and related products. The group manages its operations through two operating segments: Crude Oil and NGL.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.